Diagnostic accuracy of chromogranin A and calcitonin precursors measurements for the discrimination of ectopic ACTH secretion from Cushing's disease

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 8, 2009, Pages 2962-2965

  Zemskova, Marina S ^a   Nylen, Eric S ^b   Patronas, Nicholas J ^c   Oldfield, Edward H ^d   Becker, Kenneth L ^b   Nieman, Lynnette K ^a,e  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CHROMOGRANIN A; CORTICOTROPIN; PROCALCITONIN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; DIAGNOSTIC ACCURACY; DISEASE MARKER; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 68549101573     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0604     Document Type: Article

References (20)

1. Lindsay JR, Nieman LK 2005 Differential diagnosis and imaging in Cushing's syndrome. Endocrinol Metab Clin North Am 34:403-421
2. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler Jr GB, Loriaux DL 1991 Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 325:897-905
3. Ferrari L, Seregni E, Bajetta E, Martinetti A, Bombardieri E 1999 The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours. Anticancer Res 19:3415-3427
4. Nobels FR, Kwekkeboom DJ, Coopmans W, Schoenmakers CH, Lindemans J, De Herder WW, Krenning EP, Bouillon R, Lamberts SW 1997 Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the α-subunit of glycoprotein hormones. J Clin Endocrinol Metab 82:2622-2628
5. Nobels FR, de Herder WW, Kwekkeboom DJ, Coopmans W, Mulder A, Bouillon R, Lamberts SW 1994 Serum chromogranin A in the differential diagnosis of Cushing's syndrome. Eur J Endocrinol 131:589-593
6. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK 2005 Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 90:4955-4962
7. Becker KL, Nylén ES, White JC, Müller B, Snider Jr RH 2004 Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis - a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89:1512-1525
8. Schlumberger M, Gicquel C, Lumbroso J, Tenenbaum F, Comoy E, Bosq J, Fonseca E, Ghillani PP, Aubert B, Travagli JP, Gardet P, Parmentier C 1992 Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. J Endocrinol Invest 15:631-642
9. Becker KL, Snider RH, Silva OL, Moore CF 1978 Calcitonin heterogeneity in lung cancer and medullary thyroid cancer. Acta Endocrinol (Copenh) 89:89-99
10. Snider Jr RH, Nylen ES, Becker KL 1997 Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 45:552-560
11. Becker KL, Nylen ES, Cohen R, Snider RH 1996 Calcitonin: structure, molecular biology, and actions. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. San Diego: Academic Press, Inc.; 471-494
12. BRAHMSPCT Sensitive KRYPTOR. Instruction for use 2008. www.procalcitonin.com
13. Algeciras-Schimnich A, Preissner CM, Young Jr WF, Singh RJ, Grebe SK 2008 Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab 93:91-95
14. Algeciras-Schimnich A, Preissner CM, Theobald JP, Finseth MS, Grebe SK 2009 Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 94:861-868
15. Newcombe RG 1998 Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17:857-872
16. Motulsky H 1995 Interpreting lab tests: introducing to Bayesian thinking. In: Intuitive biostatistics. New York: Oxford University Press, Inc.; 129-136
17. Guignat L, Bidart JM, Nocera M, Comoy E, Schlumberger M, Baudin E 2001 Chromogranin A and the α-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma. Br J Cancer 84:808-812
18. Arnold R, Wilke A, Rinke A, Mayer C, Kann PH, Klose KJ, Scherag A, Hahmann M, Müller HH, Barth P 2008 Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors. Clin Gastroenterol Hepatol 6:820-827
19. Liu TH, Liu HR, Lu ZL, Wang ZY, Cao Y, Chen J, Wang Y 1993 Thoracic ectopic ACTH-producing tumors with Cushing's syndrome. Zentralblatt fur Pathologie 139:131-139
20. Gould VE, Lee I, Warren WH 1988 Immunohistochemical evaluation of neuroendocrine cells and neoplasms of the lung. Pathol Res Pract 183:200-213